Skip to main content
Shop Axis-Y Dark Spot Correcting Glow Serum
Serum
Axis-Y

Dark Spot Correcting Glow Serum

~$15.2· 1.69 fl oz
Dark spotsRadianceUneven texture

What it's good for

Key actives from our research database. Click any to read the full evidence dossier.

  • NiacinamideStrong evidenceFull dossier ↗

    A multitasker that calms redness, evens out skin tone, and helps oily skin balance out. One of the safest do-a-little-of-everything ingredients.

    Good for: Brightening, Barrier repair, Anti-inflammatory

  • Azelaic AcidStrong evidenceFull dossier ↗

    Calms redness, fades acne marks, and clears bumps, all without aggravating sensitive skin. Pregnancy-safe.

    Good for: Anti-acne, Brightening, Anti-inflammatory

  • Tranexamic AcidStrong evidenceFull dossier ↗

    Fades stubborn dark patches like melasma and deep marks left behind by acne or hormonal shifts. The one to reach for when other brighteners haven't worked.

    Good for: Brightening

Evidence behind the ingredients

Real citations from our research database, one per tracked active in this product. Click any ingredient name to read its full evidence dossier.

NiacinamideStrong evidence10 citations

A multitasker that calms redness, evens out skin tone, and helps oily skin balance out. One of the safest do-a-little-of-everything ingredients.

Moro F et al., Skin Cancer Prevention and Antiaging: Role of Nicotinamide, International Journal of Molecular Sciences 2026

2026Mechanism onlyPMID:42278444View source ↗

Passeron T et al., An Investigator-Blinded, Randomized Trial of a Broad-Spectrum Sunscreen Containing Sclareolide and Niacinamide, Dermatology and Therapy (Heidelberg) 2026

2026Positive (efficacy)PMID:41240206View source ↗

Vergilio MM et al., Topical Formulation with Niacinamide Combined with 5 MHz Ultrasound for Improving Skin Ageing, Current Medicinal Chemistry 2025

2025Positive (efficacy)PMID:39171587View source ↗
Azelaic AcidStrong evidence9 citations

Calms redness, fades acne marks, and clears bumps, all without aggravating sensitive skin. Pregnancy-safe.

Petrovici AG et al., A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations, Pharmaceuticals (Basel) 2025

2025Mechanism onlyPMID:41011144View source ↗

Feng Y et al., Azelaic Acid: Mechanisms of Action and Clinical Applications, Clinical, Cosmetic and Investigational Dermatology 2024;17:2359-2371 — antibacterial, anti-keratinizing, antimelanogenic, antioxidant, and anti-inflammatory; FDA-approved for papulopustular rosacea

2024Mechanism onlyPMID:39464747View source ↗

King A et al., A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging, Journal of Cosmetic Dermatology 2023;22(10):2650-2662 — azelaic acid more effective than vehicle for rosacea, acne, and melasma; aging evidence limited

2023Meta-analysis (positive)PMID:37550898View source ↗
Tranexamic AcidStrong evidence10 citations

Fades stubborn dark patches like melasma and deep marks left behind by acne or hormonal shifts. The one to reach for when other brighteners haven't worked.

Liang Y et al., Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: A systematic review and network meta-analysis, Journal of Cosmetic Dermatology 2024 — oral TXA + topical agents most effective delivery route

2024Meta-analysis (positive)PMID:38059683View source ↗

Tranexamic Acid Ameliorates Skin Hyperpigmentation by Downregulating Endothelin-1 Expression in Dermal Microvascular Endothelial Cells, Annals of Dermatology 2024;36(3):151-162 — mechanism study showing oral TXA suppresses endothelin-1 in vascular endothelial cells

2024Mechanism onlyPMID:38816976View source ↗

Calacattawi R, Alshahrani M, Aleid M et al., Tranexamic acid as a therapeutic option for melasma management: a meta-analysis and systematic review of randomized controlled trials, Journal of Dermatological Treatment 2024;35(1):2361106 — pooled RCT evidence that tranexamic acid significantly reduces melasma severity via plasmin-inhibition of UV-triggered melanogenesis

2024Meta-analysis (positive)PMID:38843906View source ↗

Sources: 10 clinical journals and regulatory databases across the US, EU, Korea, Japan, and China. Every entry points to a specific document. See methodology for the full list and what each outcome label means.

Similar comparisons

← Back to shop

Not medical advice. GlowPal is educational. Patch-test new products and talk to a qualified healthcare professional before changing your routine, especially if you're pregnant, nursing, or have a diagnosed skin condition. See our terms.